ARCHIVES

FDA Rile Changes Reporting Requirements for Adverse Events

This article is from The Cancer Letter archive.

Vol. 20 No. 44 | November 18, 1994

Download PDF Visit The Full Archive

Related Articles

Intensive Chemo Equivalent To Transplant For MCL

December 26, 2008

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995

New Mechanism – Cancer Control Cooperative Groups – Under Consideration By NCUI For Regional Activities

May 11, 1984

“You Can’t Legislate Biology,” Higginson Tells AACI Members

February 9, 1979

Standard Procedures Discarded in Review Of $20 Million in Texas Funds For Project Led by Wife of MD Anderson President

May 25, 2012

New Jersey Center Takes Slice of DOE Budget for Cancer

January 8, 1988